No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
GDRX250117P17500
- 11.10
- 0.000.00%
15min DelayTrading Feb 13 10:35 ET
0.00High0.00Low
0.00Open11.10Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover257.16%IV-43.98%PremiumJan 17, 2025Expiry Date13.06Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9678Delta0.0360Gamma0.34Leverage Ratio-0.0034Theta-0.0038Rho-0.33Eff Leverage0.0008Vega
Intraday
- 5D
- Daily
News
TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
Mizuho Securities Maintains GoodRx(GDRX.US) With Hold Rating
Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating
GoodRx Holdings: Navigating Leadership Transition and Legislative Uncertainty
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
GoodRx Holdings: Buy Rating Reaffirmed Amid Leadership Stability and Growth Prospects